E9-3830. Arthritis Advisory Committee; Notice of Postponement of Meeting  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is postponing the meeting of the Arthritis Advisory Committee scheduled for March 5, 2009. This meeting was announced in the Federal Register of January 29, 2009 (74 FR 5165). The postponement is due to the need to complete the review of additional data submitted by the applicant. Future meeting dates will be announced in the Federal Register.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Nicole Vesely, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-6793, FAX: 301-827-6776, e-mail: nicole.vesely@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512532. Please call the Information Line for up-to-date information on this meeting.

    Start Signature

    Dated: February 17, 2009.

    Randall W. Lutter,

    Deputy Commissioner for Policy.

    End Signature End Further Info End Preamble

    [FR Doc. E9-3830 Filed 2-23-09; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Published:
02/24/2009
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
E9-3830
Pages:
8266-8266 (1 pages)
Docket Numbers:
Docket No. FDA-2009-N-0664
PDF File:
e9-3830.pdf